Lionel Moreau
Colmar, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
SERENA-6 visual patient-reported outcomes & safety: camizestrant for emerging ESR1m advanced breast cancer during first-line endocrine-based therapy.
Journal: The oncologist
Published: May 22, 2026
Real-life management and outcomes of octogenarians with non-small-cell lung cancer: A 10-year evolution.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 22, 2026
SERENA-6 visual patient-reported outcomes and safety: camizestrant for emerging ESR1m advanced breast cancer during first-line endocrine-based therapy.
Journal: The oncologist
Published: May 22, 2026
Combined emphysema and cancer, from radiology to prognosis in patients treated by immunotherapy: An ancillary study of a prospective multicenter phase II IFCT-1802 SAVIMMUNE.
Journal: Respiratory medicine and research
Published: May 19, 2026
Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapy.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 05, 2025
First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer.
Journal: The New England journal of medicine
Published: June 02, 2025
Durvalumab in Patients With Treatment-Naive Stage IV NSCLC With an ECOG Performance Status of 2 to 3 and High PD-L1 Tumor Expression (IFCT-1802 SAVIMMUNE): A Multicenter Phase 2 Trial.
Journal: JTO clinical and research reports
Published: April 28, 2025
Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): Results of three French consecutive nationwide prospective cohorts' studies.
Journal: The Lancet regional health. Europe
Published: September 15, 2022
Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer.
Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: October 20, 2021
Tailoring maintenance chemotherapy upon response to induction chemotherapy as compared with pemetrexed continuation maintenance in advanced non-squamous NSCLC patients: Results of the IFCT-GFPC-1101 multicenter randomized phase III trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 30, 2021
First-Line Afatinib plus Cetuximab for EGFR-Mutant Non-Small Cell Lung Cancer: Results from the Randomized Phase II IFCT-1503 ACE-Lung Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 26, 2020
Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer: IFCT-1201 MODEL trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 29, 2020
Last Updated: 09/26/2026